August 5, 2026: Inventurus Knowledge Solutions Ltd (IKS Health) reported a strong set of results for the first quarter of FY27, with double-digit growth across revenue, profitability, and cash flows, supported by expanding enterprise healthcare partnerships, AI-led transformation, and a resilient client base.
Financial Highlights (Q1 FY27)
- Revenue increased 20.7% YoY to ₹8,936 million (US$97 million, +12% YoY).
- EBITDA rose 24.0% YoY to ₹2,949 million, with an EBITDA margin of 33.0%.
- Profit After Tax (PAT) grew 27.8% YoY to ₹1,937 million, translating into a 21.7% PAT margin.
- Adjusted PAT climbed 28.0% YoY to ₹2,153 million.
- Operating Cash Flow (OCF) and Free Cash Flow (FCF) grew 20.5% and 26.9% year-on-year, respectively, after adjusting for a significant upfront payment.
- Earnings Per Share (EPS) stood at ₹11.6.
- Return on Equity (ROE) was 26.4%, moderated by a higher equity base and lower currency gains.
Enterprise Client Base Continues to Expand
Inventurus now serves more than 450 enterprise healthcare customers globally.
- Revenue from the Top 10 clients surged 49% YoY to ₹4,808 million, accounting for 53.8% of total revenue.
- The average client relationship remains strong, with:
- Top 10 clients: 5.76 years
- Top 5 clients: 7.41 years
The long client tenure reflects sustained customer retention and deeper engagement with leading healthcare providers.
AI-Led Growth Strategy
The company continues to strengthen its AI capabilities through multiple strategic initiatives, including:
- Building a unified healthcare data moat for AI model training.
- Developing proprietary Small Language Models (SLMs).
- Embedding AI across healthcare workflows.
- Expanding KLAS leadership.
- Accelerating cross-selling opportunities.
- Advancing towards explainable and autonomous AI solutions.
Operating Model Transformation
Inventurus said it is driving operational efficiencies through transformation initiatives aimed at improving margins, particularly across its TruBridge Revenue Cycle Management (RCM) and Coding businesses.
Workforce and Recognition
The company ended the quarter with 12,889 employees, including:
- 1,902 clinically trained professionals
- 565 technology-focused employees
During the quarter, Inventurus also received:
- Best CFO Award
- Finance Strategy Excellence Award 2026
- A US patent for its AI-powered "Awareness-Ability-Willingness" behavioural modelling engine.
New Deal Wins
The company secured several strategic healthcare partnerships, including:
- A leading integrated health system in California for clinical data migration.
- A national musculoskeletal healthcare provider for RCM modernization.
- Expansion of services with existing clients StrideCare and Advocate Health across revenue cycle management and medical coding.
Outlook
Inventurus reiterated its focus on profitable growth and expects continued EBITDA expansion without significant equity dilution. The company is targeting ₹30 billion EBITDA by FY30, implying a 30% CAGR over the medium term.
